Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rajeshwari R. Mehta

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
The Journal of Nutritional Biochemistry|May 17, 2002
Vitamin D and cancerRajendra G. Mehta, Rajeshwari R. Mehta
International Journal of Cancer|January 9, 2004
Effect of vitamin D analog (1alpha hydroxy D5) immunoconjugated to Her-2 antibody on breast cancerVasil Punj, Jewell M Graves, Rajeshwari R Mehta
Carcinogenesis|October 1, 2005
Growth inhibition of carcinogen-transformed MCF-12F breast epithelial cells and hormone-sensitive BT-474 breast cancer cells by 1alpha-hydroxyvitamin D5Erum A Hussain-Hakimjee, Xinjian Peng, Rajeshwari R Mehta, et al.
Cancer Journal (Sudbury, Mass.)|November 2, 2005
Clinical trials involving vitamin D analogs in prostate cancerSrinivasan Vijayakumar, Rajeshwari R Mehta, Philip S Boerner, et al.
Mutation Research|March 12, 2003
Chemoprevention of mammary carcinogenesis by 1alpha-hydroxyvitamin D5, a synthetic analog of Vitamin DRajendra G Mehta, Erum A Hussain, Rajeshwari R Mehta, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 6, 2003
Efficacy and mechanism of action of 1alpha-hydroxy-24-ethyl-cholecalciferol (1alpha[OH]D5) in breast cancer prevention and therapyErum A Hussain, Rajeshwari R Mehta, Rahul Ray, et al.
Experimental Cell Research|August 14, 2012
Crosstalk between the peroxisome proliferator-activated receptor γ (PPARγ) and the vitamin D receptor (VDR) in human breast cancer cells: PPARγ binds to VDR and inhibits 1α,25-dihydroxyvitamin D3 mediated transactivationFatouma Alimirah, Xinjian Peng, Liang Yuan, et al.
Cancer Journal (Sudbury, Mass.)|January 9, 2007
Clinical trials using chemopreventive vitamin D analogs in breast cancerSrinivasan Vijayakumar, Philip S Boerner, Rajeshwari R Mehta, et al.
Molecular and Cellular Biochemistry|September 25, 2012
PPARγ antagonist GW9662 induces functional estrogen receptor in mouse mammary organ culture: potential translational significanceRajendra G Mehta, Xinjian Peng, Sarbani Roy, et al.
Plos One|November 19, 2014
Differential roles of ERα and ERβ in normal and neoplastic development in the mouse mammary glandRajendra G Mehta, Michael Hawthorne, Rajeshwari R Mehta, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
The Journal of Nutritional Biochemistry|May 17, 2002
Vitamin D and cancerRajendra G. Mehta, Rajeshwari R. Mehta
International Journal of Cancer|January 9, 2004
Effect of vitamin D analog (1alpha hydroxy D5) immunoconjugated to Her-2 antibody on breast cancerVasil Punj, Jewell M Graves, Rajeshwari R Mehta
Carcinogenesis|October 1, 2005
Growth inhibition of carcinogen-transformed MCF-12F breast epithelial cells and hormone-sensitive BT-474 breast cancer cells by 1alpha-hydroxyvitamin D5Erum A Hussain-Hakimjee, Xinjian Peng, Rajeshwari R Mehta, et al.
Cancer Journal (Sudbury, Mass.)|November 2, 2005
Clinical trials involving vitamin D analogs in prostate cancerSrinivasan Vijayakumar, Rajeshwari R Mehta, Philip S Boerner, et al.
Mutation Research|March 12, 2003
Chemoprevention of mammary carcinogenesis by 1alpha-hydroxyvitamin D5, a synthetic analog of Vitamin DRajendra G Mehta, Erum A Hussain, Rajeshwari R Mehta, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 6, 2003
Efficacy and mechanism of action of 1alpha-hydroxy-24-ethyl-cholecalciferol (1alpha[OH]D5) in breast cancer prevention and therapyErum A Hussain, Rajeshwari R Mehta, Rahul Ray, et al.
Experimental Cell Research|August 14, 2012
Crosstalk between the peroxisome proliferator-activated receptor γ (PPARγ) and the vitamin D receptor (VDR) in human breast cancer cells: PPARγ binds to VDR and inhibits 1α,25-dihydroxyvitamin D3 mediated transactivationFatouma Alimirah, Xinjian Peng, Liang Yuan, et al.
Cancer Journal (Sudbury, Mass.)|January 9, 2007
Clinical trials using chemopreventive vitamin D analogs in breast cancerSrinivasan Vijayakumar, Philip S Boerner, Rajeshwari R Mehta, et al.
Molecular and Cellular Biochemistry|September 25, 2012
PPARγ antagonist GW9662 induces functional estrogen receptor in mouse mammary organ culture: potential translational significanceRajendra G Mehta, Xinjian Peng, Sarbani Roy, et al.
Plos One|November 19, 2014
Differential roles of ERα and ERβ in normal and neoplastic development in the mouse mammary glandRajendra G Mehta, Michael Hawthorne, Rajeshwari R Mehta, et al.
Pageof 2